Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02705235
Other study ID # 0718-15-EP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2016
Est. completion date August 2016

Study information

Verified date November 2023
Source University of Nebraska
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Stress is an important determinant of pregnancy health behaviors, maternal physiology and maternal-infant health outcomes. The purpose of this study is to explain the relationship between dimensions of lifetime stress and the stress hormone cortisol in pregnant women. Additionally, the study will examine how coping styles help pregnant women to better manage stress and improve their health behaviors to achieve the goal of having a healthy baby.


Description:

Health behaviors are important modifiable factors for promoting maternal-infant health during pregnancy, and include behaviors such as diet, exercise, and avoidance of harmful substances. During pregnancy, women are often motivated to improve their lifestyle to achieve positive pregnancy outcomes; however, they may struggle to do so because certain behaviors such as excessive eating, smoking and drinking have become a means for coping with stress. Stress prior to and during pregnancy negatively impacts birth outcomes via complex behavioral and physiologic pathways. From a behavioral perspective, stress diminishes women's engagement in positive health behaviors during pregnancy. From a physiologic perspective, stress affects the regulation of cortisol, a hormone involved in fetal development and timing of delivery. Women use various coping styles to manage stress. It is unknown, however, whether certain coping styles attenuate the negative behavioral and physiologic effects of stress on birth outcomes. Therefore, the purpose of this descriptive, cross-sectional study is to examine the influence of coping styles on stress, physiologic cortisol regulation and health behaviors in a diverse sample of pregnant women (N=55) during 24-28 weeks gestation. A quantitative design with a qualitative arm will be used to: 1. explain the relationship between cortisol regulation and lifetime stress, 2. determine whether coping styles (active vs. disengaged) moderate the effect of stress on cortisol, health behaviors, and birth outcomes, and 3. describe women's qualitative experience of stress and coping and determine the extent to which the qualitative findings converge with the quantitative findings. Data will be collected over three prenatal visits during the second half of pregnancy, and will include self-report questionnaires, multiple salivary cortisol sampling, medical record data, a structured stress interview and a semi-structured qualitative interview in a subset of participants (n=12). This study will use an interview-based stress assessment in tandem with physiologic (i.e. cortisol) stress measures in pregnancy. Additionally, the qualitative data will provide a contextual understanding of pregnant women's stress and coping experiences. The research findings will inform the future development and testing of a psychosocial, coping-based intervention to promote positive health behaviors in pregnancy and birth outcomes. Furthermore, this training will provide a solid scientific foundation for the applicant to develop a career as an independent nurse-scientist in maternal-infant health promotion research, under the guidance of an experienced interdisciplinary team of mentors with complementary expertise in stress, coping health behavior, and pregnancy related research. The proposal is consistent with the National Institute of Nursing Research's (NINR) mission to support research that promotes health and prevents disease across the lifespan, builds the scientific foundation for clinical practice, and invests in the training of the next generation of nurse-scientists.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 45 Years
Eligibility Inclusion Criteria: - Single intrauterine pregnancy at least 20 weeks gestation - Aged 19 to 45 - Ability to read and speak English - Able to be reached by telephone or text most days of the week Exclusion Criteria: - Receiving or referred for care in the high-risk prenatal clinic - Have any of the following pregnancy complications or medical issues existing prior to recruitment: Cervical or uterine abnormalities, renal, hepatic or cardiac disorders, insulin-dependent diabetes, preeclampsia, regular oral steroid use in the month prior to data collection, congenital fetal abnormalities, active placenta previa, blood group isoimmunization, or other disorders/medication use that could affect cortisol levels - Regular night-shift work or reversed sleep schedule

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Nebraska Medicine Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
University of Nebraska

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cortisol Awakening Response Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for cortisol awakening response. 26 weeks gestation
Primary Diurnal Slope Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for diurnal slope. 26 weeks gestation
Primary Area Under the Curve (AUC)-Increase Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for index of the sensitivity of the cortisol response to a stressor (AUC-Increase). 26 weeks gestation
Primary Area Under the Curve (AUC)-Ground Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collectd five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for total systemic "output" throughout all salivary cortisol measures (AUC-Ground). 26 weeks gestation
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02523755 - Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia Phase 4